Filing Details

Accession Number:
0000897069-25-001036
Form Type:
13G Filing
Publication Date:
2025-05-26 20:00:00
Filed By:
Galaxy Group Funding ECI U LLC
Company:
Atai Life Sciences N.v.
Filing Date:
2025-05-27
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Galaxy Group Funding ECI U LLC 0 8,471,736 4.2%
Galaxy Group Investments LLC 0 8,471,736 4.2%
Michael E. Novogratz 0 8,471,736 4.2%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Galaxy Group Funding ECI U LLC
 
Signature:/s/ Nicholas Holderness
Name/Title:Nicholas Holderness, Chief Operating Officer
Date:05/27/2025
 
Galaxy Group Investments LLC
 
Signature:/s/ Nicholas Holderness
Name/Title:Nicholas Holderness, Chief Operating Officer
Date:05/27/2025
 
Michael E. Novogratz
 
Signature:/s/ Michael E. Novogratz
Name/Title:Michael E. Novogratz
Date:05/27/2025
Exhibit Information

https://www.sec.gov/Archives/edgar/data/1840904/000149315222005742/ex99-1.htm